<DOC>
	<DOCNO>NCT01655680</DOCNO>
	<brief_summary>This safety efficacy study evaluate experimental treatment cognitive deficit adult schizophrenia .</brief_summary>
	<brief_title>A Study Evaluate ABT-126 Treatment Cognitive Deficits Schizophrenia</brief_title>
	<detailed_description>This Phase 2 study design evaluate safety efficacy ABT-126 treat cognitive deficit subject diagnosis schizophrenia . Eligible subject take study drug add-on treatment ongoing antipsychotic treatment regimen .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<criteria>Has current Diagnostic Statistical Manual Mental Disorders , 4th Edition , Text Revision ( DSMIVTR ) diagnosis schizophrenia confirm MiniInternational Neuropsychiatric Interview ( M.I.N.I. ) . Is clinically stable receive regimen one two allowable antipsychotic medication : lack hospitalization 4 month prior initial screen visit ; take antipsychotic medication ( ) least 8 week prior baseline visit ; core positive symptom Positive Negative Syndrome Scale ( PANSS ) bad moderate severity throughout screen period least 4 week . Has diagnose treat schizophrenia least 2 year prior initial screen visit . Has continuity psychiatric care ( e.g. , mental health system , clinic physician ) least 6 month prior initial screen visit . Has identify contact person ( e.g. , family member , social worker , case worker , nurse ) provide support subject ensure compliance protocol requirement . In Investigator 's judgment , current past diagnosis schizoaffective disorder , bipolar disorder , manic episode , dementia , post traumatic stress disorder , obsessivecompulsive disorder , subject current major depressive episode . Has positive urine drug screen cocaine , phencyclidine ( PCP ) , opiates ( unless duly prescribe ) , benzodiazepine ( unless duly prescribe ) , marijuana , amphetamines Screening Period . Has current past history seizure , exception single febrile seizure occur prior 6 year age . Has clinically significant abnormal electrocardiogram ( ECG ) Screening Visit 1 determine Investigator . Has risk factor Torsades de Pointes ( TdP )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Schizophrenia</keyword>
</DOC>